SeeQC, Inc. S-1/Aamended IPO prospectus

Executive Summary

SEEQC develops control, readout and quantum–classical interfaces for quantum computers, seeking to replace complex analog infrastructure with low-power superconducting digital chips. Its current business is predominantly engineering, integration and fabrication work: FY2025 revenue grew 420% to $4.16M, but H1 2026 growth slowed to 23.7% while net loss widened to $(9.61)M. The IPO remains unpriced, with offering size, proceeds, market capitalization and buyers’ ownership stake undetermined; it would fund development and capital expenditures while also covering transaction-settlement and insider-related costs. This is an investment in future product commercialization—not an established product business—and the going-concern warning makes financing execution as consequential as technical progress.

The Offering

• Size and valuation: The preliminary offering has no price range, share count or completed post-offering capitalization; gross raise, implied market capitalization, revenue multiple and buyer stake cannot yet be computed. The $1.3B pre-money valuation used in the Allegro settlement is not an IPO valuation.
• Structure and distribution: Common-stock offering by SEEQC; the supplied terms identify no secondary allocation. Cantor Fitzgerald and BTIG lead, alongside Needham and Craig-Hallum. Underwriting discounts are up to 7.0%, with a 30-day additional-share option whose size remains blank. Nasdaq Global Market listing under SEQC is subject to approval.
• Proceeds and recipients: General corporate purposes, including product development and capital expenditures, under broad management discretion. The expected Allegro settlement consumes up to $2.0M cash and adds 106,809 shares, described as $6.0M of stock consideration; SEEQC may substitute $0.5M more stock for cash. Executive-loan forgiveness also entails company-funded tax payments.
• Capitalization bridge: Before the IPO, 6/30/2026 cash was $18.1M and stockholders’ equity $23.1M, with 10,761,714 common and 12,056,647 preferred shares outstanding. Planned adjustments include preferred conversion, a stock split, accelerated restricted-stock vesting, executive-note forgiveness, advisor shares and offering costs. “After the IPO” would additionally include net proceeds; those balances and per-share net tangible assets remain blank, preventing a quantified dilution assessment.
• Equity overhang: Pre-split awards include 3,256,084 options at a $1.46 weighted-average exercise price, 814,631 restricted-stock awards and 521,498 restricted stock units. These cannot be converted into a reliable fully diluted post-IPO count without completed split and vesting terms.
• Lock-ups: Executives, directors and substantially all existing holders generally face 180-day restrictions from the eventual prospectus date, subject to exceptions and underwriter waivers. Subsequent award registration and lock-up expiry create an unquantified share-supply overhang.

Key Financial Highlights

All figures are historical; balance-sheet figures are before the IPO. Annual periods are audited and interim periods unaudited. Dollar figures are in millions.

• Growth quality: FY2025 benefited from new customers and completed contracts; H1 2026 growth primarily reflected milestones on existing projects rather than a materially expanded portfolio.
• Margin versus overhead: Better interim gross margin did not offset selling, general and administrative expense rising 161%, driven by financing and IPO fees, finance hiring and compensation. Declining grants further reduced expense offsets.
• Cash conversion: FY2025 stock-based compensation of $1.94M and depreciation of $1.0M partly explain why operating cash burn was below net loss. H1 2026 stock-based compensation was $1.10M.
• Liquidity: H1 2026 FCF burn nearly matched the full FY2025 amount. Management concludes available resources cannot support obligations and operations for the following 12 months.
• Equity basis: Preferred stock is already classified within permanent equity at zero carrying value, despite an ≈$81.1M liquidation preference. Its conversion therefore should not be mistaken for a new cash contribution; accumulated losses of $(65.3)M coexist with positive equity supported by prior financing.

Business Model and Growth Drivers

SEEQC sells development contracts, engineering and integration services, custom chips and superconducting foundry services—not quantum processors or end-user computing. Approximately 95% of FY2025 revenue came from quantum-related activities, principally services and integration; approximately 5% came from fully commercialized product sales.

Its superconducting digital logic aims to move control and readout closer to qubits, reducing wiring, latency and cooling burdens. Some functional blocks have been tested, but the unified architecture remains incomplete; nanowatt-scale power claims are design objectives, not demonstrated commercial-system results.

Management’s growth strategy is staged adoption followed by repeatable, less-customized integrations. Full customer integration typically takes ≈12–24 months or longer. Relationships with IBM, IQM, Rigetti and NVIDIA provide ecosystem access, not proof of scaled product demand.

Manufacturing rests on an ≈8,100-square-foot, 150-millimeter-wafer foundry with a six-week fabrication cycle. A second line with Taiwan’s Industrial Technology Research Institute and an ≈13,000-square-foot Hawthorne testing facility could expand capacity, contingent on execution and funding.

Governance and Control

• Voting and ownership: Common shares carry one vote each. On an 8/1/2026 preferred-conversion basis, Johnson Revocable Trust held 14.8%, BY Capital 10.3% and executives/directors collectively 16.6%, including certain exercisable awards; final post-IPO percentages remain incomplete.
• Shareholder influence: A staggered board, removal only for cause with 66⅔% approval, and board authority to issue preferred stock constrain investor-led changes.
• Insider benefits: The IPO triggers forgiveness of $0.704M of loans to John Levy and Oleg Mukhanov, plus tax payments and compensation effects. Executive salaries also rise upon completion.
• Recurring dilution and oversight: New incentive and employee-purchase plans permit annual reserve increases of up to 5% and 1%, respectively, through 2036. Emerging-growth-company exemptions include no auditor attestation of internal controls.

Risk Assessment

• Reporting controls: Three unremediated material weaknesses cover reporting processes, technology controls and accounting staffing, increasing error and restatement exposure.
• Going concern: $18.1M cash does not resolve management’s 12-month funding shortfall; financing failure could curtail development or operations.
• Technical commercialization: Components must demonstrate integrated thermal, signal, reliability and customer-platform performance before services can become scalable products.
• Concentrated demand: Two federal agencies supplied 52% of FY2025 revenue and Customer A another 26%; contract termination, nonrenewal or appropriations delays could sharply reduce activity.
• Ecosystem dependence: Superconducting-market progress, customer willingness to outsource and competition from better-funded internal development determine whether SEEQC’s architecture gains adoption.
• Manufacturing continuity: Limited production experience, specialized inputs and an expired foundry sublease threaten yields, schedules and facility access.
• Dilution and cash leakage: Settlement shares, insider benefits, equity awards and likely further financing reduce the portion of new capital that builds the business and dilute ownership.

Investor Actionables

The eventual price must justify a transition from milestone-funded development to repeatable commercial products. Proceeds are intended to support technology and capacity investment, but settlement obligations and insider-related payments also consume resources.

• Productization: Starting from approximately 5% fully commercialized product revenue in FY2025, check whether later disclosures show recurring product sales and repeatable integrations; continued service dependence would weaken the scaling thesis.
• Customer breadth: Starting from 78% FY2025 revenue concentrated in federal agencies and Customer A, test whether new commercial customers diversify revenue; continuing concentration or contract losses would undermine demand durability.
• Capacity execution: Track the planned Hawthorne facility and second manufacturing line against disclosed progress. Operational facilities and revenue-generating customer work support the plan; delays or unresolved foundry occupancy weaken it.
• Funding economics: Compare final net proceeds and obligations with H1 2026 FCF burn of $(9.06)M. A funded development program supports the case; another urgent capital raise before commercialization would signal greater dilution risk.